$SNSS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Viracta Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Viracta Therapeutics, Inc.. Get notifications about new insider transactions in Viracta Therapeutics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 05 2011 | SNSS | SUNESIS PHARMACEUT ... | Ketchum Steven B | Sr. Vice President, ... | Option Exercise | A | 2.09 | 450,000 | 940,500 | 450,000 | |
Jul 05 2011 | SNSS | SUNESIS PHARMACEUT ... | BJERKHOLT ERIC | Sr. VP, CFO & Corp. ... | Option Exercise | A | 2.09 | 450,000 | 940,500 | 450,000 | |
Jul 05 2011 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Option Exercise | A | 2.09 | 750,000 | 1,567,500 | 750,000 | |
Mar 02 2011 | SNSS | SUNESIS PHARMACEUT ... | Ketchum Steven B | Sr. Vice President, ... | Payment of Exercise | F | 2.10 | 4,421 | 9,284 | 68,500 | 72.9 K to 68.5 K (-6.06 %) |
Mar 02 2011 | SNSS | SUNESIS PHARMACEUT ... | Ketchum Steven B | Sr. Vice President, ... | Grant | A | 0.00 | 12,053 | 0 | 72,921 | 60.9 K to 72.9 K (+19.80 %) |
Mar 02 2011 | SNSS | SUNESIS PHARMACEUT ... | BJERKHOLT ERIC | Sr. VP, CFO & Corp. ... | Payment of Exercise | F | 2.10 | 4,175 | 8,768 | 11,553 | 15.7 K to 11.6 K (-26.55 %) |
Mar 02 2011 | SNSS | SUNESIS PHARMACEUT ... | BJERKHOLT ERIC | Sr. VP, CFO & Corp. ... | Grant | A | 0.00 | 11,383 | 0 | 15,728 | 4.3 K to 15.7 K (+261.98 %) |
Mar 02 2011 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Payment of Exercise | F | 2.10 | 13,263 | 27,852 | 38,518 | 51.8 K to 38.5 K (-25.61 %) |
Mar 02 2011 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Grant | A | 0.00 | 36,160 | 0 | 51,781 | 15.6 K to 51.8 K (+231.48 %) |
Oct 08 2010 | SNSS | SUNESIS PHARMACEUT ... | BJERKHOLT ERIC | Sr. VP, CFO & Corp. ... | Buy | P | 0.31 | 100,000 | 30,850 | 438,183 | 338.2 K to 438.2 K (+29.57 %) |
Aug 03 2010 | SNSS | SUNESIS PHARMACEUT ... | BJERKHOLT ERIC | Sr. VP, CFO & Corp. ... | Payment of Exercise | F | 0.49 | 11,571 | 5,612 | 26,070 | 37.6 K to 26.1 K (-30.74 %) |
Aug 03 2010 | SNSS | SUNESIS PHARMACEUT ... | BJERKHOLT ERIC | Sr. VP, CFO & Corp. ... | Grant | A | 0.00 | 31,546 | 0 | 37,641 | 6.1 K to 37.6 K (+517.57 %) |
Aug 03 2010 | SNSS | SUNESIS PHARMACEUT ... | Ketchum Steven B | Sr. Vice President, ... | Payment of Exercise | F | 0.49 | 14,293 | 6,932 | 365,211 | 379.5 K to 365.2 K (-3.77 %) |
Aug 03 2010 | SNSS | SUNESIS PHARMACEUT ... | Ketchum Steven B | Sr. Vice President, ... | Grant | A | 0.00 | 38,969 | 0 | 379,504 | 340.5 K to 379.5 K (+11.44 %) |
Aug 03 2010 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Payment of Exercise | F | 0.49 | 30,629 | 14,855 | 93,729 | 124.4 K to 93.7 K (-24.63 %) |
Aug 03 2010 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Grant | A | 0.00 | 83,505 | 0 | 124,358 | 40.9 K to 124.4 K (+204.40 %) |
Jul 02 2010 | SNSS | SUNESIS PHARMACEUT ... | HURWITZ EDWARD | Director | Option Exercise | C | 0.00 | 11,280 | 0 | 0 | |
Jul 02 2010 | SNSS | SUNESIS PHARMACEUT ... | HURWITZ EDWARD | Director | Option Exercise | C | 0.00 | 30,739 | 0 | 0 | |
Jul 02 2010 | SNSS | SUNESIS PHARMACEUT ... | HURWITZ EDWARD | Director | Option Exercise | C | 0.00 | 457,728 | 0 | 0 | |
Jul 02 2010 | SNSS | SUNESIS PHARMACEUT ... | HURWITZ EDWARD | Director | Buy | C | 0.00 | 112,800 | 0 | 381,683 | 268.9 K to 381.7 K (+41.95 %) |
Jul 02 2010 | SNSS | SUNESIS PHARMACEUT ... | HURWITZ EDWARD | Director | Buy | C | 0.00 | 307,390 | 0 | 1,040,135 | 732.7 K to 1 M (+41.95 %) |
Jul 02 2010 | SNSS | SUNESIS PHARMACEUT ... | HURWITZ EDWARD | Director | Buy | C | 0.00 | 4,577,280 | 0 | 15,487,876 | 10.9 M to 15.5 M (+41.95 %) |
Jul 02 2010 | SNSS | SUNESIS PHARMACEUT ... | HURWITZ EDWARD | Director | Grant | A | 0.28 | 268,883 | 73,943 | 268,883 | 0 to 268.9 K |
Jul 02 2010 | SNSS | SUNESIS PHARMACEUT ... | HURWITZ EDWARD | Director | Grant | A | 0.28 | 732,745 | 201,505 | 732,745 | 0 to 732.7 K |
Jul 02 2010 | SNSS | SUNESIS PHARMACEUT ... | HURWITZ EDWARD | Director | Grant | A | 0.28 | 10,910,596 | 3,000,414 | 10,910,596 | 0 to 10.9 M |
Jul 02 2010 | SNSS | SUNESIS PHARMACEUT ... | ALTA BIOPHARMA PARTNERS III LP | Option Exercise | C | 0.00 | 11,280 | 0 | 0 | ||
Jul 02 2010 | SNSS | SUNESIS PHARMACEUT ... | ALTA BIOPHARMA PARTNERS III LP | Option Exercise | C | 0.00 | 30,739 | 0 | 0 | ||
Jul 02 2010 | SNSS | SUNESIS PHARMACEUT ... | ALTA BIOPHARMA PARTNERS III LP | Option Exercise | C | 0.00 | 457,728 | 0 | 0 | ||
Jul 02 2010 | SNSS | SUNESIS PHARMACEUT ... | ALTA BIOPHARMA PARTNERS III LP | Buy | C | 0.00 | 112,800 | 0 | 381,683 | 268.9 K to 381.7 K (+41.95 %) | |
Jul 02 2010 | SNSS | SUNESIS PHARMACEUT ... | ALTA BIOPHARMA PARTNERS III LP | Buy | C | 0.00 | 307,390 | 0 | 1,040,135 | 732.7 K to 1 M (+41.95 %) | |
Jul 02 2010 | SNSS | SUNESIS PHARMACEUT ... | ALTA BIOPHARMA PARTNERS III LP | Buy | C | 0.00 | 4,577,280 | 0 | 15,487,876 | 10.9 M to 15.5 M (+41.95 %) | |
Jul 02 2010 | SNSS | SUNESIS PHARMACEUT ... | ALTA BIOPHARMA PARTNERS III LP | Buy | P | 0.28 | 268,883 | 73,943 | 268,883 | 0 to 268.9 K | |
Jul 02 2010 | SNSS | SUNESIS PHARMACEUT ... | ALTA BIOPHARMA PARTNERS III LP | Buy | P | 0.28 | 732,745 | 201,505 | 732,745 | 0 to 732.7 K | |
Jul 02 2010 | SNSS | SUNESIS PHARMACEUT ... | ALTA BIOPHARMA PARTNERS III LP | Buy | P | 0.28 | 10,910,596 | 3,000,414 | 10,910,596 | 0 to 10.9 M | |
Jul 02 2010 | SNSS | SUNESIS PHARMACEUT ... | KERINS PATRICK J | 10% Owner | Option Exercise | C | 0.00 | 999,499 | 0 | 0 | |
Jul 02 2010 | SNSS | SUNESIS PHARMACEUT ... | KERINS PATRICK J | 10% Owner | Buy | C | 0.00 | 9,994,990 | 0 | 33,819,441 | 23.8 M to 33.8 M (+41.95 %) |
Jul 02 2010 | SNSS | SUNESIS PHARMACEUT ... | KERINS PATRICK J | 10% Owner | Buy | P | 0.28 | 23,824,451 | 6,551,724 | 23,824,451 | 0 to 23.8 M |
Jul 02 2010 | SNSS | SUNESIS PHARMACEUT ... | KOLLURI KRISHNA KITTU | 10% Owner | Option Exercise | C | 0.00 | 999,499 | 0 | 0 | |
Jul 02 2010 | SNSS | SUNESIS PHARMACEUT ... | KOLLURI KRISHNA KITTU | 10% Owner | Buy | C | 0.00 | 9,994,990 | 0 | 33,819,441 | 23.8 M to 33.8 M (+41.95 %) |
Jul 02 2010 | SNSS | SUNESIS PHARMACEUT ... | KOLLURI KRISHNA KITTU | 10% Owner | Buy | P | 0.28 | 23,824,451 | 6,551,724 | 23,824,451 | 0 to 23.8 M |
Jul 02 2010 | SNSS | SUNESIS PHARMACEUT ... | DRANT RYAN D | 10% Owner | Option Exercise | C | 0.00 | 999,499 | 0 | 0 | |
Jul 02 2010 | SNSS | SUNESIS PHARMACEUT ... | DRANT RYAN D | 10% Owner | Buy | C | 0.00 | 9,994,990 | 0 | 38,819,441 | 28.8 M to 38.8 M (+34.68 %) |
Jul 02 2010 | SNSS | SUNESIS PHARMACEUT ... | DRANT RYAN D | 10% Owner | Buy | P | 0.28 | 23,824,451 | 6,551,724 | 23,824,451 | 0 to 23.8 M |
Jul 02 2010 | SNSS | SUNESIS PHARMACEUT ... | BASKETT FOREST | 10% Owner | Option Exercise | C | 0.00 | 999,499 | 0 | 0 | |
Jul 02 2010 | SNSS | SUNESIS PHARMACEUT ... | BASKETT FOREST | 10% Owner | Buy | C | 0.00 | 9,994,990 | 0 | 33,819,441 | 23.8 M to 33.8 M (+41.95 %) |
Jul 02 2010 | SNSS | SUNESIS PHARMACEUT ... | BASKETT FOREST | 10% Owner | Buy | P | 0.28 | 23,824,451 | 6,551,724 | 23,824,451 | 0 to 23.8 M |
Jul 02 2010 | SNSS | SUNESIS PHARMACEUT ... | Growth Equity Opportunities Fu ... | 10% Owner | Option Exercise | C | 0.00 | 999,499 | 0 | 0 | |
Jul 02 2010 | SNSS | SUNESIS PHARMACEUT ... | Growth Equity Opportunities Fu ... | 10% Owner | Buy | C | 0.00 | 9,994,990 | 0 | 33,819,441 | 23.8 M to 33.8 M (+41.95 %) |
Jul 02 2010 | SNSS | SUNESIS PHARMACEUT ... | Growth Equity Opportunities Fu ... | 10% Owner | Buy | P | 0.28 | 23,824,451 | 6,551,724 | 23,824,451 | 0 to 23.8 M |
Jul 01 2010 | SNSS | SUNESIS PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Option Exercise | C | 0.00 | 18,690 | 0 | 0 | |
Jul 01 2010 | SNSS | SUNESIS PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Option Exercise | C | 0.00 | 980,809 | 0 | 0 | |
Jul 01 2010 | SNSS | SUNESIS PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 0.28 | 445,516 | 122,517 | 632,416 | 186.9 K to 632.4 K (+238.37 %) |
Jul 01 2010 | SNSS | SUNESIS PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | C | 0.00 | 186,900 | 0 | 186,900 | 0 to 186.9 K |
Jul 01 2010 | SNSS | SUNESIS PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 0.28 | 23,378,934 | 6,429,207 | 33,187,024 | 9.8 M to 33.2 M (+238.36 %) |
Jul 01 2010 | SNSS | SUNESIS PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | C | 0.00 | 9,808,090 | 0 | 9,808,090 | 0 to 9.8 M |
Jul 01 2010 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Option Exercise | C | 0.00 | 18,690 | 0 | 0 | |
Jul 01 2010 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Option Exercise | C | 0.00 | 980,809 | 0 | 0 | |
Jul 01 2010 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Buy | C | 0.00 | 186,900 | 0 | 632,416 | 445.5 K to 632.4 K (+41.95 %) |
Jul 01 2010 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Buy | C | 0.00 | 9,808,090 | 0 | 33,187,024 | 23.4 M to 33.2 M (+41.95 %) |
Jul 01 2010 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Buy | P | 0.28 | 445,516 | 122,517 | 445,516 | 0 to 445.5 K |
Jul 01 2010 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Buy | P | 0.28 | 23,378,934 | 6,429,207 | 23,378,934 | 0 to 23.4 M |
Jul 01 2010 | SNSS | SUNESIS PHARMACEUT ... | Ketchum Steven B | Sr. Vice President, ... | Option Exercise | C | 0.00 | 9,994 | 0 | 0 | |
Jul 01 2010 | SNSS | SUNESIS PHARMACEUT ... | Ketchum Steven B | Sr. Vice President, ... | Buy | C | 0.00 | 99,940 | 0 | 340,535 | 240.6 K to 340.5 K (+41.54 %) |
Jul 01 2010 | SNSS | SUNESIS PHARMACEUT ... | Ketchum Steven B | Sr. Vice President, ... | Buy | P | 0.28 | 238,243 | 65,517 | 240,595 | 2.4 K to 240.6 K (+10,129.38 %) |
Jul 01 2010 | SNSS | SUNESIS PHARMACEUT ... | BJERKHOLT ERIC | Sr. VP, CFO & Corp. ... | Option Exercise | C | 0.00 | 9,994 | 0 | 0 | |
Jul 01 2010 | SNSS | SUNESIS PHARMACEUT ... | BJERKHOLT ERIC | Sr. VP, CFO & Corp. ... | Buy | C | 0.00 | 99,940 | 0 | 338,183 | 238.2 K to 338.2 K (+41.95 %) |
Jul 01 2010 | SNSS | SUNESIS PHARMACEUT ... | BJERKHOLT ERIC | Sr. VP, CFO & Corp. ... | Buy | P | 0.28 | 238,243 | 65,517 | 238,243 | 0 to 238.2 K |
Jul 01 2010 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Option Exercise | C | 0.00 | 19,989 | 0 | 0 | |
Jul 01 2010 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Buy | C | 0.00 | 199,890 | 0 | 676,377 | 476.5 K to 676.4 K (+41.95 %) |
Jul 01 2010 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Buy | P | 0.28 | 476,487 | 131,034 | 476,487 | 0 to 476.5 K |
Jun 09 2010 | SNSS | SUNESIS PHARMACEUT ... | Fust Matthew | Director | Option Exercise | A | 0.82 | 10,000 | 8,150 | 10,000 | |
Jun 08 2010 | SNSS | SUNESIS PHARMACEUT ... | HURWITZ EDWARD | Director | Option Exercise | A | 0.82 | 10,000 | 8,150 | 10,000 | |
Jun 08 2010 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Option Exercise | A | 0.82 | 10,000 | 8,150 | 10,000 | |
Jun 08 2010 | SNSS | SUNESIS PHARMACEUT ... | STUMP DAVID C | Director | Option Exercise | A | 0.82 | 10,000 | 8,150 | 10,000 | |
Jun 08 2010 | SNSS | SUNESIS PHARMACEUT ... | Kim Helen Susan | Director | Option Exercise | A | 0.82 | 10,000 | 8,150 | 10,000 | |
Jun 08 2010 | SNSS | SUNESIS PHARMACEUT ... | YOUNG JAMES W | Director | Option Exercise | A | 0.82 | 10,000 | 8,150 | 10,000 | |
Jun 08 2010 | SNSS | SUNESIS PHARMACEUT ... | Pearce Homer L | Director | Option Exercise | A | 0.82 | 10,000 | 8,150 | 10,000 | |
May 04 2010 | SNSS | SUNESIS PHARMACEUT ... | Semon Dominique | 10% Owner | Option Exercise | X | 0.22 | 1,699,140 | 373,811 | 0 | |
May 04 2010 | SNSS | SUNESIS PHARMACEUT ... | Semon Dominique | 10% Owner | Sell | S | 0.98 | 382,542 | 373,820 | 3,921,095 | 4.3 M to 3.9 M (-8.89 %) |
May 04 2010 | SNSS | SUNESIS PHARMACEUT ... | Semon Dominique | 10% Owner | Buy | X | 0.22 | 1,699 | 374 | 4,303,637 | 4.3 M to 4.3 M (+0.04 %) |
Apr 26 2010 | SNSS | SUNESIS PHARMACEUT ... | Semon Dominique | 10% Owner | Option Exercise | X | 0.22 | 3,398,300 | 747,626 | 1,699,140 | |
Apr 26 2010 | SNSS | SUNESIS PHARMACEUT ... | Semon Dominique | 10% Owner | Option Exercise | X | 2.20 | 169,914 | 373,811 | 509,744 | |
Apr 26 2010 | SNSS | SUNESIS PHARMACEUT ... | Semon Dominique | 10% Owner | Option Exercise | X | 0.22 | 1,699,140 | 373,811 | 5,097,440 | |
Apr 26 2010 | SNSS | SUNESIS PHARMACEUT ... | Semon Dominique | 10% Owner | Option Exercise | X | 0.00 | 1,699,140 | 0 | 0 | |
Apr 26 2010 | SNSS | SUNESIS PHARMACEUT ... | Semon Dominique | 10% Owner | Option Exercise | X | 2.20 | 169,914 | 373,811 | 0 | |
Apr 26 2010 | SNSS | SUNESIS PHARMACEUT ... | Semon Dominique | 10% Owner | Option Exercise | P | 0.22 | 3,398,300 | 747,626 | 3,398,300 | |
Apr 26 2010 | SNSS | SUNESIS PHARMACEUT ... | Semon Dominique | 10% Owner | Option Exercise | P | 0.00 | 1,699,140 | 0 | 1,699,140 | |
Apr 26 2010 | SNSS | SUNESIS PHARMACEUT ... | Semon Dominique | 10% Owner | Option Exercise | P | 2.20 | 169,914 | 373,811 | 169,914 | |
Apr 26 2010 | SNSS | SUNESIS PHARMACEUT ... | Semon Dominique | 10% Owner | Sell | S | 0.94 | 793,803 | 747,604 | 2,604,497 | 3.4 M to 2.6 M (-23.36 %) |
Apr 26 2010 | SNSS | SUNESIS PHARMACEUT ... | Semon Dominique | 10% Owner | Buy | X | 0.22 | 3,398,300 | 747,626 | 3,398,300 | 0 to 3.4 M |
Apr 26 2010 | SNSS | SUNESIS PHARMACEUT ... | Semon Dominique | 10% Owner | Sell | S | 2.02 | 1,508,051 | 3,046,263 | 0 | 1.5 M to 0 (-100.00 %) |
Dec 16 2009 | SNSS | SUNESIS PHARMACEUT ... | HURWITZ EDWARD | Director | Sell | S | 2.01 | 50,391 | 101,256 | 0 | 50.4 K to 0 (-100.00 %) |
Dec 16 2009 | SNSS | SUNESIS PHARMACEUT ... | HURWITZ EDWARD | Director | Sell | S | 2.01 | 137,323 | 275,937 | 0 | 137.3 K to 0 (-100.00 %) |
Dec 16 2009 | SNSS | SUNESIS PHARMACEUT ... | HURWITZ EDWARD | Director | Sell | S | 2.01 | 2,044,750 | 4,108,721 | 0 | 2 M to 0 (-100.00 %) |
Nov 03 2009 | SNSS | SUNESIS PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Option Exercise | P | 0.22 | 62,300 | 13,706 | 62,300 | |
Nov 03 2009 | SNSS | SUNESIS PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Option Exercise | P | 0.22 | 3,269,360 | 719,259 | 3,269,360 | |
Nov 03 2009 | SNSS | SUNESIS PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Option Exercise | P | 0.22 | 6,230 | 1,371 | 18,690 | |
Nov 03 2009 | SNSS | SUNESIS PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Option Exercise | P | 0.22 | 326,936 | 71,926 | 980,809 | |
Dec 16 2009 | SNSS | SUNESIS PHARMACEUT ... | ALTA BIOPHARMA PARTNERS III LP | 10% Owner | Sell | S | 2.01 | 50,391 | 101,256 | 0 | 50.4 K to 0 (-100.00 %) |
Dec 16 2009 | SNSS | SUNESIS PHARMACEUT ... | ALTA BIOPHARMA PARTNERS III LP | 10% Owner | Sell | S | 2.01 | 137,323 | 275,937 | 0 | 137.3 K to 0 (-100.00 %) |
Dec 16 2009 | SNSS | SUNESIS PHARMACEUT ... | ALTA BIOPHARMA PARTNERS III LP | 10% Owner | Sell | S | 2.01 | 2,044,750 | 4,108,721 | 0 | 2 M to 0 (-100.00 %) |
Nov 03 2009 | SNSS | SUNESIS PHARMACEUT ... | TRAINOR III EUGENE A | 10% Owner | Option Exercise | P | 0.00 | 333,166 | 0 | 999,499 | |
Nov 03 2009 | SNSS | SUNESIS PHARMACEUT ... | TRAINOR III EUGENE A | 10% Owner | Option Exercise | P | 0.22 | 3,331,660 | 732,965 | 3,331,660 | |
Nov 03 2009 | SNSS | SUNESIS PHARMACEUT ... | ALTA BIOPHARMA PARTNERS III LP | 10% Owner | Option Exercise | P | 0.22 | 37,600 | 8,272 | 37,600 | |
Nov 03 2009 | SNSS | SUNESIS PHARMACEUT ... | ALTA BIOPHARMA PARTNERS III LP | 10% Owner | Option Exercise | P | 0.22 | 102,460 | 22,541 | 102,460 | |
Nov 03 2009 | SNSS | SUNESIS PHARMACEUT ... | ALTA BIOPHARMA PARTNERS III LP | 10% Owner | Option Exercise | P | 0.22 | 1,525,760 | 335,667 | 1,525,760 | |
Nov 03 2009 | SNSS | SUNESIS PHARMACEUT ... | ALTA BIOPHARMA PARTNERS III LP | 10% Owner | Option Exercise | P | 0.22 | 3,760 | 827 | 11,280 | |
Nov 03 2009 | SNSS | SUNESIS PHARMACEUT ... | ALTA BIOPHARMA PARTNERS III LP | 10% Owner | Option Exercise | P | 0.22 | 10,246 | 2,254 | 30,739 | |
Nov 03 2009 | SNSS | SUNESIS PHARMACEUT ... | ALTA BIOPHARMA PARTNERS III LP | 10% Owner | Option Exercise | P | 0.22 | 152,576 | 33,567 | 457,728 | |
Nov 03 2009 | SNSS | SUNESIS PHARMACEUT ... | LINEHAN CHARLES M | 10% Owner | Option Exercise | P | 0.00 | 333,166 | 0 | 999,499 | |
Nov 03 2009 | SNSS | SUNESIS PHARMACEUT ... | LINEHAN CHARLES M | 10% Owner | Option Exercise | P | 0.22 | 3,331,660 | 732,965 | 3,331,660 | |
Nov 03 2009 | SNSS | SUNESIS PHARMACEUT ... | KOLLURI KRISHNA KITTU | 10% Owner | Option Exercise | P | 0.00 | 333,166 | 0 | 999,499 | |
Nov 03 2009 | SNSS | SUNESIS PHARMACEUT ... | KOLLURI KRISHNA KITTU | 10% Owner | Option Exercise | P | 0.22 | 3,331,660 | 732,965 | 3,331,660 | |
Nov 03 2009 | SNSS | SUNESIS PHARMACEUT ... | DRANT RYAN D | 10% Owner | Option Exercise | P | 0.00 | 333,166 | 0 | 999,499 | |
Nov 03 2009 | SNSS | SUNESIS PHARMACEUT ... | DRANT RYAN D | 10% Owner | Option Exercise | P | 0.22 | 3,331,660 | 732,965 | 3,331,660 | |
Nov 03 2009 | SNSS | SUNESIS PHARMACEUT ... | KERINS PATRICK J | 10% Owner | Option Exercise | P | 0.00 | 333,166 | 0 | 999,499 | |
Nov 03 2009 | SNSS | SUNESIS PHARMACEUT ... | KERINS PATRICK J | 10% Owner | Option Exercise | P | 0.22 | 3,331,660 | 732,965 | 3,331,660 | |
Nov 03 2009 | SNSS | SUNESIS PHARMACEUT ... | BASKETT FOREST | 10% Owner | Option Exercise | P | 0.00 | 333,166 | 0 | 999,499 | |
Nov 03 2009 | SNSS | SUNESIS PHARMACEUT ... | BASKETT FOREST | 10% Owner | Option Exercise | P | 0.22 | 3,331,660 | 732,965 | 3,331,660 | |
Nov 03 2009 | SNSS | SUNESIS PHARMACEUT ... | Growth Equity Opportunities Fu ... | 10% Owner | Option Exercise | P | 0.00 | 333,166 | 0 | 999,499 | |
Nov 03 2009 | SNSS | SUNESIS PHARMACEUT ... | Growth Equity Opportunities Fu ... | 10% Owner | Option Exercise | P | 0.22 | 3,331,660 | 732,965 | 3,331,660 | |
Nov 03 2009 | SNSS | SUNESIS PHARMACEUT ... | HURWITZ EDWARD | Director | Option Exercise | P | 0.22 | 37,600 | 8,272 | 37,600 | |
Nov 03 2009 | SNSS | SUNESIS PHARMACEUT ... | HURWITZ EDWARD | Director | Option Exercise | P | 0.22 | 102,460 | 22,541 | 102,460 | |
Nov 03 2009 | SNSS | SUNESIS PHARMACEUT ... | HURWITZ EDWARD | Director | Option Exercise | P | 0.22 | 1,525,760 | 335,667 | 1,525,760 | |
Nov 03 2009 | SNSS | SUNESIS PHARMACEUT ... | HURWITZ EDWARD | Director | Option Exercise | P | 0.22 | 3,760 | 827 | 11,280 | |
Nov 03 2009 | SNSS | SUNESIS PHARMACEUT ... | HURWITZ EDWARD | Director | Option Exercise | P | 0.22 | 10,246 | 2,254 | 30,739 | |
Nov 03 2009 | SNSS | SUNESIS PHARMACEUT ... | HURWITZ EDWARD | Director | Option Exercise | P | 0.22 | 152,576 | 33,567 | 457,728 | |
Nov 03 2009 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Option Exercise | P | 0.22 | 62,300 | 13,706 | 62,300 | |
Nov 03 2009 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Option Exercise | P | 0.22 | 3,269,360 | 719,259 | 3,269,360 | |
Nov 03 2009 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Option Exercise | P | 0.22 | 6,230 | 1,371 | 18,690 | |
Nov 03 2009 | SNSS | SUNESIS PHARMACEUT ... | Misfeldt Dayton | Director | Option Exercise | P | 0.22 | 326,936 | 71,926 | 980,809 | |
Nov 03 2009 | SNSS | SUNESIS PHARMACEUT ... | Ketchum Steven B | Sr. Vice President, ... | Option Exercise | P | 0.22 | 33,310 | 7,328 | 33,310 | |
Nov 03 2009 | SNSS | SUNESIS PHARMACEUT ... | Ketchum Steven B | Sr. Vice President, ... | Option Exercise | P | 0.22 | 3,331 | 733 | 9,994 | |
Nov 03 2009 | SNSS | SUNESIS PHARMACEUT ... | BJERKHOLT ERIC | Sr. VP, CFO & Corp. ... | Option Exercise | P | 0.22 | 33,310 | 7,328 | 33,310 | |
Nov 03 2009 | SNSS | SUNESIS PHARMACEUT ... | BJERKHOLT ERIC | Sr. VP, CFO & Corp. ... | Option Exercise | P | 0.22 | 3,331 | 733 | 9,994 | |
Nov 03 2009 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Option Exercise | P | 0.22 | 66,630 | 14,659 | 66,630 | |
Nov 03 2009 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Option Exercise | P | 0.22 | 6,663 | 1,466 | 19,989 | |
Sep 02 2009 | SNSS | SUNESIS PHARMACEUT ... | Ketchum Steven B | Sr. Vice President, ... | Option Exercise | A | 0.49 | 450,000 | 220,500 | 450,000 | |
Sep 02 2009 | SNSS | SUNESIS PHARMACEUT ... | BJERKHOLT ERIC | Sr. VP and CFO | Option Exercise | A | 0.49 | 450,000 | 220,500 | 450,000 | |
Sep 02 2009 | SNSS | SUNESIS PHARMACEUT ... | Swisher Daniel N JR | President and CEO | Option Exercise | A | 0.49 | 750,000 | 367,500 | 750,000 | |
Aug 04 2009 | SNSS | SUNESIS PHARMACEUT ... | Kim Helen Susan | Director | Option Exercise | A | 0.41 | 70,000 | 28,700 | 70,000 | |
Aug 04 2009 | SNSS | SUNESIS PHARMACEUT ... | Pearce Homer L | Director | Option Exercise | A | 0.41 | 90,000 | 36,900 | 90,000 | |
Aug 04 2009 | SNSS | SUNESIS PHARMACEUT ... | Fust Matthew | Director | Option Exercise | A | 0.41 | 90,000 | 36,900 | 90,000 | |
Aug 04 2009 | SNSS | SUNESIS PHARMACEUT ... | STUMP DAVID C | Director | Option Exercise | A | 0.41 | 90,000 | 36,900 | 90,000 | |
Aug 04 2009 | SNSS | SUNESIS PHARMACEUT ... | YOUNG JAMES W | Director | Option Exercise | A | 0.41 | 90,000 | 36,900 | 90,000 | |
Jul 28 2009 | SNSS | SUNESIS PHARMACEUT ... | Kim Helen Susan | Director | Option Exercise | A | 0.34 | 30,000 | 10,275 | 30,000 | |
Jul 21 2009 | SNSS | SUNESIS PHARMACEUT ... | WARBURG PINCUS EQUITY PARTNERS ... | 10% Owner | Sell | S | 0.28 | 347,655 | 95,709 | 3,204,075 | 3.6 M to 3.2 M (-9.79 %) |
Jul 21 2009 | SNSS | SUNESIS PHARMACEUT ... | WARBURG PINCUS EQUITY PARTNERS ... | 10% Owner | Sell | S | 0.28 | 110,200 | 30,933 | 3,551,730 | 3.7 M to 3.6 M (-3.01 %) |
Jul 21 2009 | SNSS | SUNESIS PHARMACEUT ... | WARBURG PINCUS EQUITY PARTNERS ... | 10% Owner | Sell | S | 0.30 | 7,625 | 2,308 | 3,661,930 | 3.7 M to 3.7 M (-0.21 %) |
Jul 17 2009 | SNSS | SUNESIS PHARMACEUT ... | WARBURG PINCUS EQUITY PARTNERS ... | 10% Owner | Sell | S | 0.30 | 134,500 | 40,901 | 3,669,555 | 3.8 M to 3.7 M (-3.54 %) |